 | • レポートコード：GIR201114661 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール • 産業分類：新技術 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、NGSベース監視・診断試験の世界市場を調査対象にし、NGSベース監視・診断試験の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（コマーシャルアッセイ/試験、ラボ開発試験、直接消費者試験、プレコマーシャル試験）、用途別分析（外来診療/一般開業医、診療所、病院、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Agilent Technologies, Inc.、GenePath Dx、Beijing Genomics Institute (BGI)、Ancestry.com LLC、F. Hoffmann-La Roche Ltd、ArcherDX, Inc.、Laboratory Corporation of America Holdings、CENTOGENE AG、Cancer Genetics, Inc.、Illumina, Inc.、Thermo Fisher Scientific Inc.、Myriad Genetics, Inc.、HTG Molecular Diagnostics, Inc.、Siemens Healthineers, Inc.、QIAGEN N.V.、Vela Diagnostics Pte. Ltd.、Quest Diagnostics Incorporated ・企業別売上、市場シェア ・NGSベース監視・診断試験の地域別市場分析 ・NGSベース監視・診断試験の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・NGSベース監視・診断試験のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・NGSベース監視・診断試験のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・NGSベース監視・診断試験の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・NGSベース監視・診断試験の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・NGSベース監視・診断試験の種類別市場規模2015-2020：コマーシャルアッセイ/試験、ラボ開発試験、直接消費者試験、プレコマーシャル試験 ・NGSベース監視・診断試験の用途別市場規模2015-2020：外来診療/一般開業医、診療所、病院、その他 ・NGSベース監視・診断試験の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The NGS-Based Monitoring and Diagnostic Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global NGS-Based Monitoring and Diagnostic Test market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
NGS-Based Monitoring and Diagnostic Test market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, NGS-Based Monitoring and Diagnostic Test market has been segmented into:
Commercial Assays/Tests
Laboratory Developed Tests
Direct to Consumer Test
Pre-Commercial Tests
By Application, NGS-Based Monitoring and Diagnostic Test has been segmented into:
Out-Patient Clinics/General Practitioners
Diagnostic Centers
Hospitals
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global NGS-Based Monitoring and Diagnostic Test market presented in the report. This section sheds light on the sales growth of different regional and country-level NGS-Based Monitoring and Diagnostic Test markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global NGS-Based Monitoring and Diagnostic Test market.
The report offers in-depth assessment of the growth and other aspects of the NGS-Based Monitoring and Diagnostic Test market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and NGS-Based Monitoring and Diagnostic Test Market Share Analysis
NGS-Based Monitoring and Diagnostic Test competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, NGS-Based Monitoring and Diagnostic Test sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the NGS-Based Monitoring and Diagnostic Test sales, revenue and market share for each player covered in this report.
The major players covered in NGS-Based Monitoring and Diagnostic Test are:
Agilent Technologies, Inc.
GenePath Dx
Beijing Genomics Institute (BGI)
Ancestry.com LLC
F. Hoffmann-La Roche Ltd
ArcherDX, Inc.
Laboratory Corporation of America Holdings
CENTOGENE AG
Cancer Genetics, Inc.
Illumina, Inc.
Thermo Fisher Scientific Inc.
Myriad Genetics, Inc.
HTG Molecular Diagnostics, Inc.
Siemens Healthineers, Inc.
QIAGEN N.V.
Vela Diagnostics Pte. Ltd.
Quest Diagnostics Incorporated
Among other players domestic and global, NGS-Based Monitoring and Diagnostic Test market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 NGS-Based Monitoring and Diagnostic Test Market Overview
1.1 Product Overview and Scope of NGS-Based Monitoring and Diagnostic Test
1.2 Classification of NGS-Based Monitoring and Diagnostic Test by Type
1.2.1 Global NGS-Based Monitoring and Diagnostic Test Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Type in 2019
1.2.3 Commercial Assays/Tests
1.2.4 Laboratory Developed Tests
1.2.5 Direct to Consumer Test
1.2.6 Pre-Commercial Tests
1.3 Global NGS-Based Monitoring and Diagnostic Test Market by Application
1.3.1 Overview: Global NGS-Based Monitoring and Diagnostic Test Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Out-Patient Clinics/General Practitioners
1.3.3 Diagnostic Centers
1.3.4 Hospitals
1.3.5 Others
1.4 Global NGS-Based Monitoring and Diagnostic Test Market by Regions
1.4.1 Global NGS-Based Monitoring and Diagnostic Test Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of NGS-Based Monitoring and Diagnostic Test (2015-2025)
1.4.3 North America (USA, Canada and Mexico) NGS-Based Monitoring and Diagnostic Test Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) NGS-Based Monitoring and Diagnostic Test Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) NGS-Based Monitoring and Diagnostic Test Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) NGS-Based Monitoring and Diagnostic Test Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) NGS-Based Monitoring and Diagnostic Test Status and Prospect (2015-2025)
2 Company Profiles
2.1 Agilent Technologies, Inc.
2.1.1 Agilent Technologies, Inc. Details
2.1.2 Agilent Technologies, Inc. Major Business
2.1.3 Agilent Technologies, Inc. SWOT Analysis
2.1.4 Agilent Technologies, Inc. Product and Services
2.1.5 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2018-2019)
2.2 GenePath Dx
2.2.1 GenePath Dx Details
2.2.2 GenePath Dx Major Business
2.2.3 GenePath Dx SWOT Analysis
2.2.4 GenePath Dx Product and Services
2.2.5 GenePath Dx NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2018-2019)
2.3 Beijing Genomics Institute (BGI)
2.3.1 Beijing Genomics Institute (BGI) Details
2.3.2 Beijing Genomics Institute (BGI) Major Business
2.3.3 Beijing Genomics Institute (BGI) SWOT Analysis
2.3.4 Beijing Genomics Institute (BGI) Product and Services
2.3.5 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2018-2019)
2.4 Ancestry.com LLC
2.4.1 Ancestry.com LLC Details
2.4.2 Ancestry.com LLC Major Business
2.4.3 Ancestry.com LLC SWOT Analysis
2.4.4 Ancestry.com LLC Product and Services
2.4.5 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2018-2019)
2.5 F. Hoffmann-La Roche Ltd
2.5.1 F. Hoffmann-La Roche Ltd Details
2.5.2 F. Hoffmann-La Roche Ltd Major Business
2.5.3 F. Hoffmann-La Roche Ltd SWOT Analysis
2.5.4 F. Hoffmann-La Roche Ltd Product and Services
2.5.5 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2018-2019)
2.6 ArcherDX, Inc.
2.6.1 ArcherDX, Inc. Details
2.6.2 ArcherDX, Inc. Major Business
2.6.3 ArcherDX, Inc. Product and Services
2.6.4 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2018-2019)
2.7 Laboratory Corporation of America Holdings
2.7.1 Laboratory Corporation of America Holdings Details
2.7.2 Laboratory Corporation of America Holdings Major Business
2.7.3 Laboratory Corporation of America Holdings Product and Services
2.7.4 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2018-2019)
2.8 CENTOGENE AG
2.8.1 CENTOGENE AG Details
2.8.2 CENTOGENE AG Major Business
2.8.3 CENTOGENE AG Product and Services
2.8.4 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2018-2019)
2.9 Cancer Genetics, Inc.
2.9.1 Cancer Genetics, Inc. Details
2.9.2 Cancer Genetics, Inc. Major Business
2.9.3 Cancer Genetics, Inc. Product and Services
2.9.4 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2018-2019)
2.10 Illumina, Inc.
2.10.1 Illumina, Inc. Details
2.10.2 Illumina, Inc. Major Business
2.10.3 Illumina, Inc. Product and Services
2.10.4 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2018-2019)
2.11 Thermo Fisher Scientific Inc.
2.11.1 Thermo Fisher Scientific Inc. Details
2.11.2 Thermo Fisher Scientific Inc. Major Business
2.11.3 Thermo Fisher Scientific Inc. Product and Services
2.11.4 Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2018-2019)
2.12 Myriad Genetics, Inc.
2.12.1 Myriad Genetics, Inc. Details
2.12.2 Myriad Genetics, Inc. Major Business
2.12.3 Myriad Genetics, Inc. Product and Services
2.12.4 Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2018-2019)
2.13 HTG Molecular Diagnostics, Inc.
2.13.1 HTG Molecular Diagnostics, Inc. Details
2.13.2 HTG Molecular Diagnostics, Inc. Major Business
2.13.3 HTG Molecular Diagnostics, Inc. Product and Services
2.13.4 HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2018-2019)
2.14 Siemens Healthineers, Inc.
2.14.1 Siemens Healthineers, Inc. Details
2.14.2 Siemens Healthineers, Inc. Major Business
2.14.3 Siemens Healthineers, Inc. Product and Services
2.14.4 Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2018-2019)
2.15 QIAGEN N.V.
2.15.1 QIAGEN N.V. Details
2.15.2 QIAGEN N.V. Major Business
2.15.3 QIAGEN N.V. Product and Services
2.15.4 QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2018-2019)
2.16 Vela Diagnostics Pte. Ltd.
2.16.1 Vela Diagnostics Pte. Ltd. Details
2.16.2 Vela Diagnostics Pte. Ltd. Major Business
2.16.3 Vela Diagnostics Pte. Ltd. Product and Services
2.16.4 Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2018-2019)
2.17 Quest Diagnostics Incorporated
2.17.1 Quest Diagnostics Incorporated Details
2.17.2 Quest Diagnostics Incorporated Major Business
2.17.3 Quest Diagnostics Incorporated Product and Services
2.17.4 Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global NGS-Based Monitoring and Diagnostic Test Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 NGS-Based Monitoring and Diagnostic Test Players Market Share
3.2.2 Top 10 NGS-Based Monitoring and Diagnostic Test Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global NGS-Based Monitoring and Diagnostic Test Revenue and Market Share by Regions
4.2 North America NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
4.3 Europe NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
4.5 South America NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
5 North America NGS-Based Monitoring and Diagnostic Test Revenue by Countries
5.1 North America NGS-Based Monitoring and Diagnostic Test Revenue by Countries (2015-2020)
5.2 USA NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
5.3 Canada NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
5.4 Mexico NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
6 Europe NGS-Based Monitoring and Diagnostic Test Revenue by Countries
6.1 Europe NGS-Based Monitoring and Diagnostic Test Revenue by Countries (2015-2020)
6.2 Germany NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
6.3 UK NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
6.4 France NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
6.5 Russia NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
6.6 Italy NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
7 Asia-Pacific NGS-Based Monitoring and Diagnostic Test Revenue by Countries
7.1 Asia-Pacific NGS-Based Monitoring and Diagnostic Test Revenue by Countries (2015-2020)
7.2 China NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
7.3 Japan NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
7.4 Korea NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
7.5 India NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
8 South America NGS-Based Monitoring and Diagnostic Test Revenue by Countries
8.1 South America NGS-Based Monitoring and Diagnostic Test Revenue by Countries (2015-2020)
8.2 Brazil NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
8.3 Argentina NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue NGS-Based Monitoring and Diagnostic Test by Countries
9.1 Middle East & Africa NGS-Based Monitoring and Diagnostic Test Revenue by Countries (2015-2020)
9.2 Saudi Arabia NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
9.3 UAE NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
9.4 Egypt NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
9.5 South Africa NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global NGS-Based Monitoring and Diagnostic Test Revenue and Market Share by Type (2015-2020)
10.2 Global NGS-Based Monitoring and Diagnostic Test Market Forecast by Type (2019-2024)
10.3 Commercial Assays/Tests Revenue Growth Rate (2015-2025)
10.4 Laboratory Developed Tests Revenue Growth Rate (2015-2025)
10.5 Direct to Consumer Test Revenue Growth Rate (2015-2025)
10.6 Pre-Commercial Tests Revenue Growth Rate (2015-2025)
11 Global NGS-Based Monitoring and Diagnostic Test Market Segment by Application
11.1 Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Application (2015-2020)
11.2 NGS-Based Monitoring and Diagnostic Test Market Forecast by Application (2019-2024)
11.3 Out-Patient Clinics/General Practitioners Revenue Growth (2015-2020)
11.4 Diagnostic Centers Revenue Growth (2015-2020)
11.5 Hospitals Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global NGS-Based Monitoring and Diagnostic Test Market Size Forecast (2021-2025)
12.1 Global NGS-Based Monitoring and Diagnostic Test Market Size Forecast (2021-2025)
12.2 Global NGS-Based Monitoring and Diagnostic Test Market Forecast by Regions (2021-2025)
12.3 North America NGS-Based Monitoring and Diagnostic Test Revenue Market Forecast (2021-2025)
12.4 Europe NGS-Based Monitoring and Diagnostic Test Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific NGS-Based Monitoring and Diagnostic Test Revenue Market Forecast (2021-2025)
12.6 South America NGS-Based Monitoring and Diagnostic Test Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa NGS-Based Monitoring and Diagnostic Test Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global NGS-Based Monitoring and Diagnostic Test Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of NGS-Based Monitoring and Diagnostic Test by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global NGS-Based Monitoring and Diagnostic Test Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market NGS-Based Monitoring and Diagnostic Test Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global NGS-Based Monitoring and Diagnostic Test Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Agilent Technologies, Inc. Corporate Information, Location and Competitors
Table 7. Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Major Business
Table 8. Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Total Revenue (USD Million) (2017-2018)
Table 9. Agilent Technologies, Inc. SWOT Analysis
Table 10. Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions
Table 11. Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. GenePath Dx Corporate Information, Location and Competitors
Table 13. GenePath Dx NGS-Based Monitoring and Diagnostic Test Major Business
Table 14. GenePath Dx NGS-Based Monitoring and Diagnostic Test Total Revenue (USD Million) (2018-2019)
Table 15. GenePath Dx SWOT Analysis
Table 16. GenePath Dx NGS-Based Monitoring and Diagnostic Test Product and Solutions
Table 17. GenePath Dx NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Beijing Genomics Institute (BGI) Corporate Information, Location and Competitors
Table 19. Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Major Business
Table 20. Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Total Revenue (USD Million) (2017-2018)
Table 21. Beijing Genomics Institute (BGI) SWOT Analysis
Table 22. Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Product and Solutions
Table 23. Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Ancestry.com LLC Corporate Information, Location and Competitors
Table 25. Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Major Business
Table 26. Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Total Revenue (USD Million) (2017-2018)
Table 27. Ancestry.com LLC SWOT Analysis
Table 28. Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Product and Solutions
Table 29. Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. F. Hoffmann-La Roche Ltd Corporate Information, Location and Competitors
Table 31. F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Major Business
Table 32. F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Total Revenue (USD Million) (2017-2018)
Table 33. F. Hoffmann-La Roche Ltd SWOT Analysis
Table 34. F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Product and Solutions
Table 35. F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. ArcherDX, Inc. Corporate Information, Location and Competitors
Table 37. ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Major Business
Table 38. ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Total Revenue (USD Million) (2017-2018)
Table 39. ArcherDX, Inc. SWOT Analysis
Table 40. ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions
Table 41. ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Laboratory Corporation of America Holdings Corporate Information, Location and Competitors
Table 43. Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Major Business
Table 44. Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Total Revenue (USD Million) (2017-2018)
Table 45. Laboratory Corporation of America Holdings SWOT Analysis
Table 46. Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Product and Solutions
Table 47. Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. CENTOGENE AG Corporate Information, Location and Competitors
Table 49. CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Major Business
Table 50. CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Total Revenue (USD Million) (2017-2018)
Table 51. CENTOGENE AG SWOT Analysis
Table 52. CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Product and Solutions
Table 53. CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Cancer Genetics, Inc. Corporate Information, Location and Competitors
Table 55. Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Major Business
Table 56. Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Total Revenue (USD Million) (2017-2018)
Table 57. Cancer Genetics, Inc. SWOT Analysis
Table 58. Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions
Table 59. Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Illumina, Inc. Corporate Information, Location and Competitors
Table 61. Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Major Business
Table 62. Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Total Revenue (USD Million) (2017-2018)
Table 63. Illumina, Inc. SWOT Analysis
Table 64. Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions
Table 65. Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Thermo Fisher Scientific Inc. Corporate Information, Location and Competitors
Table 67. Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Major Business
Table 68. Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Total Revenue (USD Million) (2017-2018)
Table 69. Thermo Fisher Scientific Inc. SWOT Analysis
Table 70. Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions
Table 71. Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Myriad Genetics, Inc. Corporate Information, Location and Competitors
Table 73. Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Major Business
Table 74. Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Total Revenue (USD Million) (2017-2018)
Table 75. Myriad Genetics, Inc. SWOT Analysis
Table 76. Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions
Table 77. Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. HTG Molecular Diagnostics, Inc. Corporate Information, Location and Competitors
Table 79. HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Major Business
Table 80. HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Total Revenue (USD Million) (2017-2018)
Table 81. HTG Molecular Diagnostics, Inc. SWOT Analysis
Table 82. HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions
Table 83. HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Siemens Healthineers, Inc. Corporate Information, Location and Competitors
Table 85. Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Major Business
Table 86. Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Total Revenue (USD Million) (2017-2018)
Table 87. Siemens Healthineers, Inc. SWOT Analysis
Table 88. Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions
Table 89. Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. QIAGEN N.V. Corporate Information, Location and Competitors
Table 91. QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Major Business
Table 92. QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Total Revenue (USD Million) (2017-2018)
Table 93. QIAGEN N.V. SWOT Analysis
Table 94. QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Product and Solutions
Table 95. QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Vela Diagnostics Pte. Ltd. Corporate Information, Location and Competitors
Table 97. Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Major Business
Table 98. Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Total Revenue (USD Million) (2017-2018)
Table 99. Vela Diagnostics Pte. Ltd. SWOT Analysis
Table 100. Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Product and Solutions
Table 101. Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Quest Diagnostics Incorporated Corporate Information, Location and Competitors
Table 103. Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Major Business
Table 104. Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Total Revenue (USD Million) (2017-2018)
Table 105. Quest Diagnostics Incorporated SWOT Analysis
Table 106. Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Product and Solutions
Table 107. Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Global NGS-Based Monitoring and Diagnostic Test Revenue (Million USD) by Players (2015-2020)
Table 109. Global NGS-Based Monitoring and Diagnostic Test Revenue Share by Players (2015-2020)
Table 110. Global NGS-Based Monitoring and Diagnostic Test Revenue (Million USD) by Regions (2015-2020)
Table 111. Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Regions (2015-2020)
Table 112. North America NGS-Based Monitoring and Diagnostic Test Revenue by Countries (2015-2020)
Table 113. North America NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Countries (2015-2020)
Table 114. Europe NGS-Based Monitoring and Diagnostic Test Revenue (Million USD) by Countries (2015-2020)
Table 115. Asia-Pacific NGS-Based Monitoring and Diagnostic Test Revenue (Million USD) by Countries (2015-2020)
Table 116. South America NGS-Based Monitoring and Diagnostic Test Revenue by Countries (2015-2020)
Table 117. South America NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Countries (2015-2020)
Table 118. Middle East and Africa NGS-Based Monitoring and Diagnostic Test Revenue (Million USD) by Countries (2015-2020)
Table 119. Middle East and Africa NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Countries (2015-2020)
Table 120. Global NGS-Based Monitoring and Diagnostic Test Revenue (Million USD) by Type (2015-2020)
Table 121. Global NGS-Based Monitoring and Diagnostic Test Revenue Share by Type (2015-2020)
Table 122. Global NGS-Based Monitoring and Diagnostic Test Revenue Forecast by Type (2021-2025)
Table 123. Global NGS-Based Monitoring and Diagnostic Test Revenue by Application (2015-2020)
Table 124. Global NGS-Based Monitoring and Diagnostic Test Revenue Share by Application (2015-2020)
Table 125. Global NGS-Based Monitoring and Diagnostic Test Revenue Forecast by Application (2021-2025)
Table 126. Global NGS-Based Monitoring and Diagnostic Test Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. NGS-Based Monitoring and Diagnostic Test Picture
Figure 2. Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Type in 2019
Figure 3. Commercial Assays/Tests Picture
Figure 4. Laboratory Developed Tests Picture
Figure 5. Direct to Consumer Test Picture
Figure 6. Pre-Commercial Tests Picture
Figure 7. NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Application in 2019
Figure 8. Out-Patient Clinics/General Practitioners Picture
Figure 9. Diagnostic Centers Picture
Figure 10. Hospitals Picture
Figure 11. Others Picture
Figure 12. Global NGS-Based Monitoring and Diagnostic Test Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America NGS-Based Monitoring and Diagnostic Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe NGS-Based Monitoring and Diagnostic Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific NGS-Based Monitoring and Diagnostic Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America NGS-Based Monitoring and Diagnostic Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa NGS-Based Monitoring and Diagnostic Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global NGS-Based Monitoring and Diagnostic Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global NGS-Based Monitoring and Diagnostic Test Revenue Share by Players in 2019
Figure 20. Global Top 5 Players NGS-Based Monitoring and Diagnostic Test Revenue Market Share in 2019
Figure 21. Global Top 10 Players NGS-Based Monitoring and Diagnostic Test Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global NGS-Based Monitoring and Diagnostic Test Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Regions (2015-2020)
Figure 25. Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Regions in 2018
Figure 26. North America NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
Figure 27. Europe NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
Figure 29. South America NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
Figure 31. North America NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Countries (2015-2020)
Figure 32. North America NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Countries in 2019
Figure 33. USA NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
Figure 34. Canada NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
Figure 35. Mexico NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
Figure 36. Europe NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Countries (2015-2020)
Figure 37. Europe NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Countries in 2019
Figure 38. Germany NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
Figure 39. UK NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
Figure 40. France NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
Figure 41. Russia NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
Figure 42. Italy NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Countries in 2019
Figure 45. China NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
Figure 46. Japan NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
Figure 47. Korea NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
Figure 48. India NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
Figure 50. South America NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Countries (2015-2020)
Figure 51. South America NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Countries in 2019
Figure 52. Brazil NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
Figure 53. Argentina NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
Figure 57. UAE NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
Figure 58. Egypt NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
Figure 59. South Africa NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2015-2020)
Figure 60. Global NGS-Based Monitoring and Diagnostic Test Revenue Share by Type (2015-2020)
Figure 61. Global NGS-Based Monitoring and Diagnostic Test Revenue Share by Type in 2019
Figure 62. Global NGS-Based Monitoring and Diagnostic Test Market Share Forecast by Type (2021-2025)
Figure 63. Global Commercial Assays/Tests Revenue Growth Rate (2015-2020)
Figure 64. Global Laboratory Developed Tests Revenue Growth Rate (2015-2020)
Figure 65. Global Direct to Consumer Test Revenue Growth Rate (2015-2020)
Figure 66. Global Pre-Commercial Tests Revenue Growth Rate (2015-2020)
Figure 67. Global NGS-Based Monitoring and Diagnostic Test Revenue Share by Application (2015-2020)
Figure 68. Global NGS-Based Monitoring and Diagnostic Test Revenue Share by Application in 2019
Figure 69. Global NGS-Based Monitoring and Diagnostic Test Market Share Forecast by Application (2021-2025)
Figure 70. Global Out-Patient Clinics/General Practitioners Revenue Growth Rate (2015-2020)
Figure 71. Global Diagnostic Centers Revenue Growth Rate (2015-2020)
Figure 72. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global NGS-Based Monitoring and Diagnostic Test Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global NGS-Based Monitoring and Diagnostic Test Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America NGS-Based Monitoring and Diagnostic Test Revenue Market Forecast (2021-2025)
Figure 78. Europe NGS-Based Monitoring and Diagnostic Test Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific NGS-Based Monitoring and Diagnostic Test Revenue Market Forecast (2021-2025)
Figure 80. South America NGS-Based Monitoring and Diagnostic Test Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa NGS-Based Monitoring and Diagnostic Test Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
獣医迅速検査の世界市場 2020年 Market Overview The global Veterinary Rapid Test market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Veterinary Rapid Test m…- 梅毒迅速検査キットの世界市場 2020年 Market Overview The Syphilis Rapid Test Kit market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- B型肝炎診断テストの世界市場 2020年 Market Overview The global Hepatitis B Diagnostic Tests market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hepatitis B Diag…
- 肝炎ウイルス診断テストの世界市場 2020年 Market Overview The global Hepatitis Viruses Diagnostic Tests market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hepatitis …
- 肝炎診断テストの世界市場 2020年 Market Overview The global Hepatitis Diagnostics Test market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hepatitis Diagnost…